Focused Wealth Management, Inc - TONIX PHARMACEUTICALS HLDG C ownership

TONIX PHARMACEUTICALS HLDG C's ticker is and the CUSIP is 890260862. A total of 53 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Focused Wealth Management, Inc ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q1 2023$131
+50.6%
2220.0%0.00%
Q4 2022$872220.0%0.00%
Q3 2022$0222
+909.1%
0.00%
Q2 2022$0220.00%
Other shareholders
TONIX PHARMACEUTICALS HLDG C shareholders Q2 2022
NameSharesValueWeighting ↓
IFP Advisors, Inc 14$170.00%
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders